Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrase strand transfer inhibitors (INSTIs) are a class of antiretroviral drugs that specifically target the integrase enzyme, which is essential for the replication of retroviruses such as HIV. The integrase enzyme catalyzes the insertion (integration) of viral DNA into the host cell’s genome—a critical step in establishing infection and enabling viral replication.
INSTIs bind to the active site of HIV integrase after 3′-processing has occurred, where they chelate two divalent metal ions (usually magnesium) required for catalysis. By occupying this site, INSTIs prevent the strand transfer reaction—the step where processed viral DNA is covalently linked to host DNA—thus blocking integration and halting further viral replication.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrase Strand Transfer Inhibitor.